TY - JOUR
T1 - Procedure-related bleeding in elective percutaneous coronary interventions
AU - Ndrepepa, Gjin
AU - Stephan, Tilman
AU - Fiedler, Katrin Anette
AU - Guerra, Elena
AU - Kufner, Sebastian
AU - Kastrati, Adnan
N1 - Publisher Copyright:
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Background: Prognostic impact of procedure-related bleeding in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI) remains incompletely investigated. The aim of this study was to investigate the association between peri-PCI bleeding and 1-year outcome of patients with stable CAD. Materials and methods: The study included 9035 patients with stable CAD who underwent elective PCI. Bleeding within 30 days of PCI was defined using the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 1-year mortality. Results: Bleeding occurred in 844 patients (9·3%). Actionable bleeding (BARC class ≥ 2) occurred in 442 patients (4·9%). There were 210 deaths (2·3%) at 1 year following PCI: 41 deaths among patients with bleeding and 169 deaths among patients without bleeding [Kaplan-Meier estimates of mortality, 4·9% and 2·1%; odds ratio = 2·41, 95% confidence interval (CI) 1·73-3·36, P < 0·001]. The association between bleeding and mortality remained significant after adjustment for baseline risk variables (adjusted hazard ratio = 1·87, 95% CI 1·27-2·76, P = 0·002). Bleeding increased the discriminatory power of the model regarding prediction of 1-year mortality (absolute and relative integrated discrimination improvement, 0·006% and 16·3%, respectively, P = 0·001). Conclusions: In patients with stable CAD undergoing elective PCI, the occurrence of bleeding within 30 days of the procedure was associated with increased risk of death at 1 year after PCI. These findings suggest that procedure-related bleeding may contribute to less than optimal results of PCI in terms of mortality reduction in patients with stable CAD.
AB - Background: Prognostic impact of procedure-related bleeding in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI) remains incompletely investigated. The aim of this study was to investigate the association between peri-PCI bleeding and 1-year outcome of patients with stable CAD. Materials and methods: The study included 9035 patients with stable CAD who underwent elective PCI. Bleeding within 30 days of PCI was defined using the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 1-year mortality. Results: Bleeding occurred in 844 patients (9·3%). Actionable bleeding (BARC class ≥ 2) occurred in 442 patients (4·9%). There were 210 deaths (2·3%) at 1 year following PCI: 41 deaths among patients with bleeding and 169 deaths among patients without bleeding [Kaplan-Meier estimates of mortality, 4·9% and 2·1%; odds ratio = 2·41, 95% confidence interval (CI) 1·73-3·36, P < 0·001]. The association between bleeding and mortality remained significant after adjustment for baseline risk variables (adjusted hazard ratio = 1·87, 95% CI 1·27-2·76, P = 0·002). Bleeding increased the discriminatory power of the model regarding prediction of 1-year mortality (absolute and relative integrated discrimination improvement, 0·006% and 16·3%, respectively, P = 0·001). Conclusions: In patients with stable CAD undergoing elective PCI, the occurrence of bleeding within 30 days of the procedure was associated with increased risk of death at 1 year after PCI. These findings suggest that procedure-related bleeding may contribute to less than optimal results of PCI in terms of mortality reduction in patients with stable CAD.
KW - Bleeding
KW - Mortality
KW - Myocardial infarction
KW - Percutaneous coronary intervention
KW - Stable coronary artery disease
UR - http://www.scopus.com/inward/record.url?scp=84923450841&partnerID=8YFLogxK
U2 - 10.1111/eci.12408
DO - 10.1111/eci.12408
M3 - Article
C2 - 25645583
AN - SCOPUS:84923450841
SN - 0014-2972
VL - 45
SP - 263
EP - 273
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 3
ER -